Medicover ABLTS:0RPS +0.42%89 Interest Coverage is 2.81 as of Mar. 2026, which is 19% below its 10-year median of 3.47. GuruFocus rates LTS:0RPS with a GF Score™ of 89/100 and a GF Value™ of kr233.91 (Fairly Valued). The stock has 5 warning signs investors should review. Among 454 Healthcare Providers & Services companies, Medicover AB ranks worse than 77.53% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Medicover AB's
Operating Income
for the
three
months ended in Mar. 2026 was kr503 Mil. Medicover AB's Interest Expense for the
three
months ended in Mar. 2026 was kr-179 Mil.
Medicover AB's interest coverage for the quarter that ended in Mar. 2026 was 2.81.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Medicover AB's Interest Coverage or its related term are showing as below:
LTS:0RPS'
s Interest Coverage Range Over the Past 10 Years
Min: 1.19 Med: 3.47 Max: 7.93
Current: 2.54
LTS:0RPS's Interest Coverage is ranked worse than 77.53% of 454
companies
in the Healthcare Providers & Services industry
Industry Median: 8
vs LTS:0RPS: 2.54
Medicover AB (LTS:0RPS) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Medicover AB Interest Coverage Related Terms
Medicover AB Interest Coverage Historical Data
* Premium members only.
The historical data trend for Medicover AB's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
LTS:0RPS vs HCA, THC, DVA: Interest Coverage Comparison
For the Medical Care Facilities subindustry, Medicover AB's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medicover AB Interest Coverage vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Medicover AB's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Medicover AB's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medicover AB (LTS:0RPS) has a Interest Coverage of 2.81 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Medicover AB and its competitors. This is 19% below median its historical median of 3.47. Over the past decade, Medicover AB's Interest Coverage has ranged from 1.19 to 7.93. According to the industry distribution chart, Medicover AB ranks #352 out of 454 companies in the Healthcare Providers & Services industry, placing it in the top 77.5%.
Is Medicover AB's Interest Coverage too high?
Medicover AB's current Interest Coverage of 2.81 is 19% below median its 10-year median of 3.47. Over the past 10 years, this metric has ranged from a low of 1.19 to a high of 7.93. The Healthcare Providers & Services industry median Interest Coverage is 8.00. Medicover AB's value of 2.81 is 64.9% below this industry median. Based on the distribution chart, Medicover AB ranks #352 out of 454 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Medicover AB has a GF Score™ of 89/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Medicover AB's Interest Coverage compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Medicover AB ranks #352 out of 454 companies for Interest Coverage. This places Medicover AB in the lower half of its industry. The industry median Interest Coverage is 8.00. Medicover AB's value of 2.81 is 64.9% below this benchmark. Historically, Medicover AB's own Interest Coverage has ranged from 1.19 to 7.93 over the past decade. While the company's 10-year median is 3.47 vs. the industry median of 8.00, Medicover AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Healthcare Providers & Services company?
The median Interest Coverage among Healthcare Providers & Services companies is 8.00, based on 454 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medicover AB's current Interest Coverage of 2.81 is 64.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Medicover AB and its competitors. For the Healthcare Providers & Services industry, the median Interest Coverage is 8.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medicover AB's current Interest Coverage is 2.81, which is 19% below median its own 10-year median of 3.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medicover AB stock overvalued right now?
Based on GuruFocus' analysis, Medicover AB (LTS:0RPS) is currently considered Fairly Valued. The stock's GF Value™ is kr233.91, compared to a current price of kr238.00 — trading 1.7% above its estimated fair value. The current Interest Coverage is 2.81, which is 19% below median its 10-year median of 3.47 and 64.9% below the Healthcare Providers & Services industry median of 8.00. Medicover AB's overall GF Score™ is 89/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Medicover AB (LTS:0RPS), the current Interest Coverage is 2.81 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medicover AB (LTS:0RPS) Overvalued in 2026?
Based on GuruFocus' analysis, Medicover AB stock appears to be overvalued.
The current stock price of kr238.00 is trading 1.7% above its estimated GF Value™ of kr233.91.
GuruFocus considers Medicover AB to be Fairly Valued.
Key valuation signals for LTS:0RPS:
Interest Coverage: 2.81 (19% below median its 10-year median of 3.47)
GF Value™: kr233.91 vs. price of kr238.00 (1.7% above fair value)
Industry Position: 64.9% below the Healthcare Providers & Services median (#352 of 454)
No single metric tells the full story. See the LTS:0RPS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medicover AB is an international healthcare and diagnostic services provider. It offers a broad spectrum of healthcare services via an extensive network of ambulatory clinics, hospitals, specialty-care facilities, and laboratories. Medicover offers its services through two reportable segments: Healthcare Services, which generates the maximum revenue, and Diagnostic Services. Diagnostic Services offer a broad range of laboratory testing in all clinical pathology areas, and Healthcare Services offer medical care and related services by operating on an Integrated Healthcare and Fee-For-Service model across different countries. Geographically, the company derives maximum revenue from Germany, and the rest from Poland, India, Ukraine, Romania, and other countries.
89GF Score
Get the complete analysis for LTS:0RPS
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0RPS has been successfully added to your 
